IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT

被引:706
|
作者
FURITSU, T
TSUJIMURA, T
TONO, T
IKEDA, H
KITAYAMA, H
KOSHIMIZU, U
SUGAHARA, H
BUTTERFIELD, JH
ASHMAN, LK
KANAYAMA, Y
MATSUZAWA, Y
KITAMURA, Y
KANAKURA, Y
机构
[1] OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
[2] OSAKA UNIV,SCH MED,DEPT PATHOL,SUITA,OSAKA 565,JAPAN
[3] OSAKA UNIV,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN
[4] MAYO CLIN & MAYO FDN,DEPT INTERNAL MED,ROCHESTER,MN 55905
[5] HANSON CTR CANC RES,LEUKAEMIA RES UNIT,ADELAIDE,SOUTH AFRICA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1993年 / 92卷 / 04期
关键词
PROTOONCOGENE C-KIT; POINT MUTATION; LEUKEMIA; TYROSINE KINASE; ACTIVATION;
D O I
10.1172/JCI116761
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.
引用
收藏
页码:1736 / 1744
页数:9
相关论文
共 50 条
  • [21] ALTERED METABOLISM OF MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) IN CUTANEOUS MASTOCYTOSIS
    LONGLEY, BJ
    MORGANROTH, GS
    TYRRELL, L
    DING, TG
    ANDERSON, DM
    WILLIAMS, DE
    HALABAN, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18): : 1302 - 1307
  • [22] Human mast cells synthesise and store c-kit ligand (stem cell factor)
    McGill, JI
    Zhang, S
    Anderson, DF
    Church, MK
    Holgate, ST
    Roche, WR
    VISION RESEARCH, 1996, 36 : 308 - 308
  • [23] Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor
    Georgin-Lavialle, Sophie
    Lhermitte, Ludovic
    Suarez, Felipe
    Yang, Ying
    Letard, Sebastien
    Hanssens, Katia
    Feger, Frederic
    Renand, Amedee
    Brouze, Chantal
    Canioni, Danielle
    Asnafi, Vahid
    Chandesris, Marie-Olivia
    Aouba, Achille
    Gineste, Paul
    Macintyre, Elizabeth
    Mansfield, Colin D.
    Moussy, Alain
    Lepelletier, Yves
    Dubreuil, Patrice
    Hermine, Olivier
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (01) : 47 - 52
  • [24] EFFECT OF MURINE MAST-CELL GROWTH-FACTOR (C-KIT PROTOONCOGENE LIGAND) ON COLONY FORMATION BY HUMAN MARROW HEMATOPOIETIC PROGENITOR CELLS
    BROXMEYER, HE
    COOPER, S
    LU, L
    HANGOC, G
    ANDERSON, D
    COSMAN, D
    LYMAN, SD
    WILLIAMS, DE
    BLOOD, 1991, 77 (10) : 2142 - 2149
  • [25] The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation
    Lukacs, NW
    Kunkel, SL
    Strieter, RM
    Evanoff, HL
    Kunkel, RG
    Key, ML
    Taub, DD
    BLOOD, 1996, 87 (06) : 2262 - 2268
  • [26] IMMUNOHISTOCHEMICAL LOCALIZATION OF STEM-CELL FACTOR (SCF) WITH COMPARISON OF ITS RECEPTOR C-KIT PROTOONCOGENE PRODUCT (C-KIT) IN MELANOCYTIC TUMORS
    TAKAHASHI, H
    SAITOH, K
    KISHI, H
    PARSONS, PG
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1995, 427 (03): : 283 - 288
  • [27] REGULATION OF MAST-CELL PROLIFERATION, MATURATION AND FUNCTION BY STEM-CELL FACTOR, A LIGAND FOR THE C-KIT RECEPTOR
    GALLI, SJ
    TSAI, M
    WERSHIL, BK
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (2-4) : 234 - 237
  • [28] MUTATION AT THE C-KIT LOCUS OF RATS RESULTS IN ANEMIA AND MAST-CELL DEFICIENCY
    KITAMURA, Y
    KASUGAI, T
    TSUJIMURA, T
    HIROTA, S
    MORII, E
    NOMURA, S
    NIWA, Y
    KONDO, K
    NISHIMUNE, Y
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 466 - 466
  • [29] REGULATION OF MOUSE AND HUMAN MAST-CELL DEVELOPMENT, SURVIVAL AND FUNCTION BY STEM-CELL FACTOR, THE LIGAND FOR THE C-KIT RECEPTOR
    GOLLI, SJ
    TSAI, M
    WERSHIL, BK
    TAM, SY
    COSTA, JJ
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 51 - 53
  • [30] EFFECT OF MAST-CELL GROWTH-FACTOR (C-KIT LIGAND) ON CLONOGENIC LEUKEMIC PRECURSOR CELLS
    GOSELINK, HM
    WILLIAMS, DE
    FIBBE, WE
    WESSELS, HW
    BEVERSTOCK, GC
    WILLEMZE, R
    FALKENBURG, JHF
    BLOOD, 1992, 80 (03) : 750 - 757